19th Sep 2025 A plain language summary of the MonumenTAL-1 study: talquetamab for relapsed/ refractory multiple myeloma
12th Jan 2022 Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary
